Font Size: a A A

Gan Capsules By Clinical Trials For The Treatment Of Coronary Heart Disease Premature Ventricular Contractions (qiyinliangxu Folder Stasis Syndrome)

Posted on:2012-07-29Degree:MasterType:Thesis
Country:ChinaCandidate:Y TianFull Text:PDF
GTID:2204330338950837Subject:Integrative Medicine
Abstract/Summary:PDF Full Text Request
Purpose:preliminary evaluation on the treatment of coronary heart disease GanSen capsule qi and Yin ventricular premature beat two empty carry the safety of stasis And effectiveness.Method: a random ized, double-blind, placebo controlled method, parallel 60 patients with coronary heart disease (ventricular premature beat two empty qi and Yin carry stasis in 35 years of age and older) to 70 years old by the patients: the ratio of 30 cases randomly divided into trial group and control group, 30 cases ,Take GanSen capsule, each group, four of the oral; three times a day The control group placebo capsules each time, three times a day four of oral treatment 4 weeks. Observe two groups before and after the treatment of ventricular premature beat happen times holter (24 hours), electrocardiogram curative effect, evaluation to improve syndromes, to evaluate the efficacy; And the drug safety index before and after comparison, including: blood, urine, and routine, electrocardiogram, liver function (ALT, AST), kidney (BUN, Cr), and possible adverse reactions. Statistical analysis using SPSS16.0 statistical software, level with Ridit analysis, measurement data using t-test, count data using a chi-square test, data that results in this study.Results:1. Effect of assessment: in premature beat control the total effective rate of group a, 66.47%, the comparison group total effectiveness 40.00% group a, for better than control group (P < 0.05);Chamber group compared with earlier times, group compared with significant difference (P < 0.05);In traditional Chinese medicine in sickness curative effect for 80.00% 4.75%more efficient group, efficient, better than control group for group aloin (P < 0.05).2. Safety evaluation: test process, not found GanCan capsule has adverse reactions. Good safelyConclusion:1. GanSen capsules can significantly reduce the coronary heart disease (ventricular premature beat two empty qi and Yin carry stasis) patients room early happen times;2. GanSen capsule can effectively improve the coronary heart disease (ventricular premature beat two empty qi and Yin carry stasis) patient's symptoms and TCM symptoms;3. GanSen capsule treatment of coronary heart disease ventricular premature beat has better security.
Keywords/Search Tags:GanSen capsule, Coronary heart disease room early, Qi and Yin deficiency carry stasis two
PDF Full Text Request
Related items
Study Of Ren Shen Jian Xin Capsule On Treating Coronary Heart Disease With Qi Deficiency And Blood Stasis Type.
The Clinical Observation Of Tianxiangdan Capsule In Treating Angina Pectoris In Coronary Heart Disease(Syndrome Of Qi Deficiency And Blood Stasis)
The Effects Of Fu-Yuan Capsule On LPA And Cardiac Functtion In Coronary Heart Disease With Syndrome Of Qi-Deficiency And Blood Stasis
Clinical Observation On Liver And Spleen Deficiency Early Anxiety Of Shuganjieyu Capsule In Treating Coronary Heart Disease After Percutaneous Coronary Intervention
MicroRNA Different Expression On Coronary Heart Disease With Qi-deficiency Blood Stasis Syndrome And Qi-deficiency Phlegm Stasis Syndrome And Treatment Of Tongguan Capsule
The Fuyuan Capsule Effect On TXB2,6-Keto-PGF1a,NO,ROS Of Coronary Heart Disease With Qi-Deficiency And Blood Syasis Syndrome And The Study Of Relative Mechanisms
Guanxinkang Capsule Treatment Of Angina Pectoris (heart And Kidney Deficiency Blood Stasis), Clinical Research
The Clinical Curative Effect Study Of Shengui Capsule In The Treatment Of Patients With Coronary Heart Disease And Chronic Heart Failure With Yang Deficiency And Blood Stasis Syndrome
The Clinical Observation Of Guanxin Tongmai Capsule On Patients With Stable Coronary Heart Disease Ejection Fraction Retention, Heart Failure, Qi And Yin Deficiency, And Heart Stasis Syndrome
10 Study Of Yixintong Capsule Combined With Nicorandil In The Treatment Of Coronary Microcirculation Disorder After PCI